Main menu

NEW YORK, Sept 21 – Nanogen (Nasdaq: NGEN) announced Thursday that the US National Cancer Institute had purchased its NanoChip system for the full list price of $150,000, but the institute’s Advanced Technology Center said the deal does not signal a preference for one technology over another.